Tesamorelin
An FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body composition optimization and visceral fat reduction.
Details
- Category
- growth-hormone
- Administration
- Subcutaneous injection
- Prescription Required
- Yes
- Also known as
- Egrifta
Common Uses
- Visceral fat reduction
- Growth hormone stimulation
- Body composition
- Metabolic health